Maball 500mg Rituximab Injection

Rituximab 500mg and 100mg price in India

Rituximab 500 mg Injection price

Price: INR 8900/Vial | MRP INR 35826.5

Packaging Size Vial
Strength 500mg/100mg
Composition Rituximab
Treatment Cancer
Brand MABALL 500
Manufacturer Hetero Healthcare

FAQ - Rituximab

Rituximab 500mg and 100mg injection is used to treat non-Hodgkin’s lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukaemia), granulomatosis with polyangiitis, and microscopic polyangiitis.

 

Rituxan must be given directly into the bloodstream to be effective. So, instead of a pill or an injection, it is given as an infusion, which is a needle inserted into a vein. Infusions are administered by trained medical personnel. When you get your Rituxan infusion, it will be combined with another medication called methotrexate.

 

Side effects of rituximab

  • Back pain.
  • black, tarry stools.
  • bloating or swelling of the face, arms, hands, lower legs, or feet.
  • blood in the urine or stools.
  • body aches or pain.
  • burning or stinging of the skin.
  • chest pain or tightness.
  • difficulty with breathing.

Rituximab’s direct effects include complement-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity, while its indirect effects include structural changes, apoptosis, and cancer cell sensitization to chemotherapy.

Rituximab’s direct effects include complement-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity, while its indirect effects include structural changes, apoptosis, and cancer cell sensitization to chemotherapy.

Rituximab-arrx is approved for the treatment of adult patients suffering from:

As a single agent, relapsed or refractory, low-grade or follicular, CD20-positive B-cell NHL.

previously untreated follicular, CD20-positive B-cell NHL in combination with first-line chemotherapy, and as single-agent maintenance therapy in patients who achieve a complete or partial response to a rituximab product in combination with chemotherapy.
After first-line cyclophosphamide, vincristine, and prednisone (CVP) chemotherapy, a single agent was used to treat non-progressing (including stable disease), low-grade, CD20-positive B-cell NHL.
CD20-positive diffuse large B-cell NHL previously untreated with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP), or other anthracycline-based chemotherapy regimens.

Price: INR 21500 ($265)

  • Back pain.
  • black, tarry stools.
  • bloating or swelling of the face, arms, hands, lower legs, or feet.
  • blood in the urine or stools.
  • body aches or pain.
  • burning or stinging of the skin.
  • chest pain or tightness.
  • difficulty with breathing.